We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

The White Test: A Real Benefit?

Gareth Morris-Stiff, MB, BCh, MD, FRCS; Shahid Farid, MB, BCh; K. Raj Prasad, FRCS
Arch Surg. 2009;144(2):193-197. doi:10.1001/archsurg.2008.539.
Text Size: A A A
Published online


We read with interest the article by Nadalin et al1 in which they, using their White test, reported a 74% bile leak rate, which allowed identification and control of biliary radicals, reducing the leak rate to 5.1%. We concur with McFadden in his accompanying critique that it is a pity that additional details were not provided as to the number of patients who underwent resection. In addition, the inclusion of the indication for surgery (primary or metastatic hepatic carcinoma or cholangiocarcinoma), extent of resection, and morbidity as a result of bile leaks would also have added value to the article. We are also surprised that, even after instillation of the fat emulsion, the clinical leak rate was 5.1%. This represents only a 2.9% reduction in leak rate compared with their own series referenced in the article. Unfortunately, there is no reference to this data, and no statistical comparison was performed. Furthermore, if 74% of patients had a leak identified on the White test, the authors' limited data would suggest that the vast majority of these were not clinically significant, otherwise the rate in their unpublished series would be expected to have been much higher than 8%. This would suggest that the White test has a significant false-positive rate, at least in terms of significant leaks, and there is also still a significant false-negative rate, as there was a 5.1% leak rate following the introduction of the test.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections